JENNIFER JEROME: Open Payments
NPI 1134661531 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,599 in 110 payments from 21 companies in 2025. Trend: 2023 $1,356 · 2024 $1,873 · 2025 $2,599
Food & beverage: $2,358Education: $241
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $474 |
| ABBVIE INC. | 30 | $467 |
| Axsome Therapeutics, Inc. | 14 | $450 |
| Vanda Pharmaceuticals Inc. | 14 | $231 |
| Teva Pharmaceuticals USA, Inc. | 3 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $138 |
| Astellas Pharma US Inc | 2 | $110 |
| Alkermes, Inc. | 5 | $109 |
| Novo Nordisk Inc | 3 | $78 |
| Optinose US, Inc. | 4 | $76 |
Products named: Auvelity, AIRSUPRA, VRAYLAR, FANAPT, CAPLYTA, Xhance, REXULTI, ARISTADA.
Industry payments across CT — which companies pay providers there.
